MedicSen

MedicSen, the company that is revolutionizing diabetes treatment achieved technical viability on their glycemic forecast algorithm and needle-free insulin smartpatch. Find out what’s happening behind of scenes in Founder interview with Eduardo W. Jorgensen.

Tell us something about MedicSen.

Shaping the future of healthcare management through artificial intelligence and automated needle-free drug administration

How did you get here?

While finishing my medical studies I went to NYC to learn about entrepreneurship, the idea got bigger and we received investment from a Dubai firm (TURN8). After that we established strategic partnerships in UK and now we have our technology ready for the next phases: algorithm forecasts future glucose levels with less than 0.5mmol/L as mean error on one hour predictions, which is awesome since it doesn´t modify any of the patients decisions (next step is to reach less than 0.4mmol/L on 1:30 hours prediction). Insulin smartpatch managed to make a blue molecule similar to insulin go through the skin without needles (next steps are to miniaturize it, decrease absorption time and perform human skin tests).

What is your inspiration for creating your company?

Two years ago I was in a consult as a GP intern and I saw how a 10 year old girl with Diabetes rejected the treatment because her friends laughed at her, she had to adapt her routine to the disease, constantly use needles and she and her mom were constantly worried because they didn´t know if something as simple as going for a hike would be good or bad for her health. I felt the need to change this in order to improve quality of life within this patients and I gathered a wonderful team of engineers, artificial intelligence and business analyst to help secure development and commercial viability. After several iterations we identified potential of the solution to be adapted to a wide range of chronic diseases in the future (epilepsy, high blood pressure, clotting diseases etc…), thus being able to help more people and decrease chronic diseases associated costs by improving control and awareness.

What have been your biggest challenges as a Tech4Good Startup?

Access to health datasets in order to train the algorithm has been very hard. Also securing the talent needed for the team is not easy when little funds are available. And finally understanding all the legal ecosystem is a must, but unintuitive for scientific entrepreneurs.

What is your biggest learning from Dotforge?

Partnerships are the key to success. Without Dotforge´s help MedicSen wouldn´t have been able to improve it´s business model, implement an efficient pipeline for development and have testing opportunities within the NHS.

What is the most used piece of advice you have had to developing your startup?

Use lean startup and build MVPs that can be tested and improved; It is better to open conversations with big players even if you still don´t have your technology ready, because they are slow as a snail; A cheap lawyer ends up being expensive.